Fig 2. Odds of SARS-CoV-2 sero-positivity among study participants with or without co-morbid conditions (diabetes, stroke, heart disease, hypertension, and asthma).

(A) represents data in overall study population, (B) on urban slum population and (C) on inhabitants of the neighboring non-slum areas. Data was presented as adjusted odds ratio (aOR) with 95% confidence interval. Bayesian multivariate generalized linear mixed model (MGLMM) was used to estimate the p-value. The Bayesian MGLMM was fitted with sociodemographic factors, BMI, Bacillus Calmette-Guérin (BCG) vaccination, and comorbidities, as fixed effects and cluster effects were taken as a random effect.